Campaigners have welcomed the approval of a new drug in Scotland for patients with chronic myeloid leukaemia (CML).
Asciminib, also known as Scemblix, has a different method of action to the drugs currently used, so may be beneficial to patients w...
1 year ago
Significant healthcare inequalities remain in the UK for people living with sickle cell disease (SCD), campaigners say.
Full results from the Sickle Cell Health Awareness, Perspectives and Experiences (SHAPE) survey, published this week, come a ye...
1 year ago
